226
Fulcrum Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
208
FY23:
242
FY24:
250
FY25:
357
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.00
FY22:
19.2
FY23:
15.5
FY24:
10.8
FY25:
8.80
Total assets
Change from FY21 to FY25
millions USD
FY21:
235
FY22:
227
FY23:
258
FY24:
261
FY25:
366
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
19.2
FY22:
16.7
FY23:
13.7
FY24:
11.0
FY25:
13.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.26
FY22:
11.0
FY23:
8.83
FY24:
6.64
FY25:
4.24
(positive)
Change from FY21 to FY25
millions USD
FY21:
212
FY22:
199
FY23:
235
FY24:
243
FY25:
349
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
235
FY22:
227
FY23:
258
FY24:
261
FY25:
366
All amounts in millions USD